Ceftazidime, gentamicin, and rifampicin, in combination, kill biofilms of mucoid Pseudomonas aeruginosa

Canadian Journal of Microbiology

Volumn 43, Issue 11, 1997, Pages 999-1004

  Ghani, M ^a   Soothill, J S ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Biofilm; Pseudomonas aeruginosa; Rifampicin

Indexed keywords

CEFTAZIDIME; GENTAMICIN; MUCIN; RIFAMPICIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BIOFILM; BRONCHUS SECRETION; CYSTIC FIBROSIS; HUMAN; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STRAIN DIFFERENCE;

BRONCHUS; NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0031468189     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/m97-144     Document Type: Article

References (29)

1. Acocella, G. 1983. Pharmacokinetics and metabolism of rifampin in humans. Rev. Inf. Dis. 5: S428-S432.
2. Anwar, H., Dasgupta, H., Lam, K., and Costerton, J.W. 1989. Tobramycin resistance of mucoid P. aeruginosa biofilm grown under iron limitation. J. Antimicrob. Chemother. 24: 647-655.
3. Boucher, J.C., Martinez-Salazar, J., Schurr, M.J., Mudd, M.H., Yu, H., and Deretic, V. 1996. Two distinct loci affecting conversion to mucoidy in Pseudomonas aeruginosa in cystic fibrosis encode homologs of the serine protease HtrA. J. Bacteriol. 178: 511-523.
4. Brown, M.R.W., Allison, D.G., and Gilbert, P. 1988. Resistance of bacterial biofilms to antibiotics: a growth related effect? J. Antimicrob. Chemother. 22: 777-783.
5. Chin, N.X., and Neu, H.C. 1987. Synergy of imipenem - a novel carbapenem, and rifampicin and ciprofloxacin against Pseudomonas aeruginosa, Serratia marcescens, and Enterobacter species. Chemotherapy, 33: 183-188.
6. Daikos, G.L., Lolans, V.T., and Jackson, G.G. 1991. First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use. Antimicrob. Agents Chemother. 35: 117-123.
7. Dibdin, G.H., Assinder, S.J., Nichols, W.W., and Lambert, P.A. 1996. Mathematical model of β-lactam penetration into a biofilm of Pseudomonas aeruginosa while undergoing simultaneous inactivation by released β-lactamases. J. Antimicrob. Chemother. 38: 757-769.
8. Gilbert, P., Das, J., and Foley, I. 1997. Biofilm susceptibility to antimicrobials. Adv. Dent. Res. 11: 160-167.
9. Gordon, C.A., Hodges, N.A., and Marriott, C. 1988. Antibiotic interaction and diffusion through alginate and exopolysaccharide of cystic fibrosis-derived Pseudomonas aeruginosa. J. Antimicrob. Chemother. 22: 667-674.
10. Govan, J.R.W. 1975. Mucoid strains of P. aeruginosa. The influence of culture medium on the stability of mucus production. J. Med. Microbiol. 8: 513-522.
11. Hodgson, A.E. 1994. Biofilm specific physiologies of Staphylococcus aureus. Ph.D. thesis, University of Manchester, Manchester, U.K.
12. Hodgson, A.E., Nelson, S.M., Brown, M.R.W., and Gilbert, P.A. 1995. Simple in vitro model for the growth control of bacterial biofilms. J. Appl. Bacteriol. 79: 87-93.
13. Ichimiya, T., Takeoka, K., Hiramatsu, K., Hirai, K., Yamasaki, T., and Nasu, M. 1996. The influence of azithromycin on the biofilm formation of Pseudomonas aeruginosa in vitro. 42: 186-191.
14. Jacquot, J., Tournier, M.J., Carmona, G.T., Puchelle, E., Chazalette, P.J., and Sadoul, P. 1983. Proteins of bronchial secretion in mucoviscidosis. Role of infection. Bull. Eur. Physiopathol. Respir. 19: 453-458.
15. Kilbourn, J.P. 1978. Bacterial contents and ionic composition of sputum in cystic fibrosis. Lancet, 8054: 334.
16. Korvick, J.A., Peacock, J.E., Muder, R.R., Wheeler, R.R., and Yu, V.L. 1992. Addition of rifampicin to combination antibiotic therapy for Pseudomonas aeruginosa bacteraemia: prospective trial using the zelen protocol. Antimicrob. Agents Chemother. 36: 620-625.
17. Kucers, A., and Bennett, N.M. 1989. The use of antibiotics, a comprehensive review with clinical emphasis. 4th ed. Heinemann Medical Books, Oxford, U.K.
18. Kwart, H., Moseley, W.W., and Katz, M. 1963. The chemical characterisation of human tracheobronchial secretion: a possible clue to the origin of fibrocystic mucus. Ann. N.Y. Acad. Sci. 106: 709-721.
19. Lam, J., Chan, R., Lam, K., and Costerton, J.W. 1980. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect. Immun. 28: 546-556.
20. Mason, N.A., Johnson, C.E., and O'Brien, M.A. 1992. Stability of ceftazidime and tobramycin sulfate in peritoneal dialysis solution. Am. J. Hosp. Pharm. 49: 1139-1142.
21. Matthews, L.W., Spector, S., Lemm, J., and Potter, J.L. 1963. Studies on pulmonary secretions; 1. The overall chemical composition of pulmonary secretions from patients with CF, bronchiectasis, and laryngectomy. Am. Rev. Respir. Dis. 88: 199-202.
22. Nichols, W.W., Dorrington, S.M., Slack, M.P.E., and Walmsley, H.L. 1988. Inhibition of tobramycin diffusion by binding to alginate. Antimicrob. Agents Chemother. 32: 518-523.
23. Stewart, P.S. 1994. Biofilm accumulation model that predicts antibiotic resistance of Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 38: 1052-1058.
24. Valdes, J.M., Baltch, A.L., Smith, R.P., Hammer, M.C., and Ritz, W.J. 1990. The effect of rifampicin on the in-vitro activity of cefpirome or ceftazidime in combination with aminoglycosides against P. aeruginosa. J. Antimicrob. Chemother. 25: 575-584.
25. Xiong, Y.Q, Caillon, J., Drugeon, H., Potel, G., and Baron, D. 1996. The effect of rifampicin on adaptive resistance of Pseudomonas aeruginosa to aminoglycosides. J. Antimicrob. Chemother. 37: 993-998.
26. E). Infect. Immun. 64: 2774-2781.
27. Yu, H., Mudd, M., Boucher, J.C., Schurr, M.J., and Deretic, V. 1997. Identification of the algZ gene upstream of the response regulator algR and its participation in control of alginate production in Pseudomonas aeruginosa. J. Bacteriol. 179: 187-193.
28. Yu, V.L., Zuravleff, J.J., Peacock, J.E., DeHertogh, D., and Tashjian, L. 1984. Addition of rifampicin to carboxypencillin - aminoglycoside combination for the treatment of P. aeruginosa infection: clinical experience with four patients. Antimicrob. Agents Chemother. 26: 575-577.
29. Zuraleff, J.J., Yu, V.L., and Yee, R.B. 1983. Ticarcillin -tobramycin - rifampin: in vitro synergy of the triplet combination against Pseudomonas aeruginosa. J. Lab. Clin. Med. 101: 896-902.